InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Ende Eric J, Director. Insider active across 2 companies, notably Matinas BioPharma Holdings, Inc.. Cumulatively, 4 reports have been recorded. Total volume traded: €64k. The latest transaction was disclosed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
15,000 shares@ €2.011946.8% of flowADSsSEC:0001104659-22-067241:0
Ideal exit: 25 Feb 2023 (T+270)
15,000 shares@ €2.282553.2% of flowADSsSEC:0001104659-22-066222:0
Ideal exit: 21 Feb 2023 (T+270)
4,800 shares0Common Stock, par value $0.0001 per shareSEC:0000905718-21-000832
4,800 shares0Common Stock, par value $0.0001 per shareSEC:0000905718-21-000832:0
4 of 4 declarations
About Ende Eric J
Eric J. Ende is a Board Member at Matinas BioPharma Holdings, Inc. and AVADEL PHARMACEUTICALS PLC. He contributes to the company's strategy and important decision-making. His experience in the pharmaceutical sector is an asset for the company's future direction.
